The 12 closest competitors and alternatives to PredxBio, Inc. — ranked by similarity to what PredxBio, Inc. actually does, not by market-cap band.
Subscribe to see PredxBio, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
PredxBio, Inc. is an artificial intelligence-driven, tissue-based biomarker company located in Pittsburgh, Pennsylvania. The firm specializes in tissue intelligence to support drug development decisions and improve survival curves in immunotherapy cancer treatments.
PredxBio, Inc. is a company headquartered in United States. It has raised at least $1.2M across the 2 funding rounds on record. Its most recent funding round raised $601,321 in August 2023. Xcout tracks 8 named people at PredxBio, Inc., including B. Dusty Majumdar (CHIEF EXECUTIVE OFFICER).
2 more named people on record for PredxBio, Inc., with roles, board committees and tenure — see the full roster →
At least $1.2M raised across the 2 rounds on record. Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $601,321 | — | |
| Seed | $601,321 | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Ranked by semantic similarity — how close each company is to PredxBio, Inc. by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Close match by what they do
Deep Rx Inc. is a predictive analytics and healthcare technology company headquartered in Pittsburgh, Pennsylvania. The company advances AI-driven solutions for precision medicine, including developing COLOXIS, an artificial intelligence-powered chemotherapy drug-selection tool.
Healthcare AI
PreciseDx, Inc. provides an AI-powered platform called OncoIntelligence and its specific product, PreciseBreast, to analyze tissue samples and determine breast cancer recurrence risk. The company serves oncologists, surgeons, pathologists, payors, and patients by offering objective risk stratification and phenotype insights within hours.
Software
Predix develops investigational deep learning software intended for medical image analysis in radiology and pathology, specifically for tumor and multi-cancer detection. The cloud-enabled system uses artificial intelligence to help radiologists and pathologists prioritize studies, highlight regions of interest, and support evaluations while meeting Canadian healthcare data standards.
Close match by what they do
Xlue Inc. is an artificial intelligence company based in Pittsburgh, Pennsylvania, building a health world model for general clinical intelligence and training cancer prediction tools on patient medical records.
Close match by what they do
Pierogi Therapeutics, Inc is a biotechnology company located in Pittsburgh, Pennsylvania, focusing on AI and machine learning applications in therapeutics.
Close match by what they do
Paige.AI, Inc. provides AI technology and services for digital pathology to improve cancer diagnosis and patient care. Headquartered in New York City, the company develops computational pathology products that assist medical professionals and healthcare institutions. Its platform leverages machine learning to analyze clinical slides and advance pathology research.
Healthtech
PathAI, Inc. is a healthcare technology company that develops artificial intelligence and machine-learning tools for digitizing and analyzing pathology images. It serves biopharmaceutical companies, research organizations, and pathology laboratories by supporting drug development, clinical trials, and diagnostic workflows.
Software Development
ArteraAI is a United States-based medical artificial intelligence company that develops AI-enabled predictive and prognostic tests to help personalize therapy for cancer patients. The company utilizes a multi-modal artificial intelligence platform to analyze digital pathology and clinical data.
Biotech, AI/ML
Pangea Biomed, founded in 2018 and headquartered in Tel Aviv, Israel, is a biotechnology company focused on cancer. Its mission is to democratize precision oncology, bringing deep tumor intelligence to drug development and treatment nomination.
Close match by what they do
Pictor Labs, Inc. is a virtual staining company based in California that leverages artificial intelligence and digital technology to advance pathology and tissue insights.
AI/ML
Pathos AI, Inc. is an artificial-intelligence-driven biopharmaceutical company that uses multimodal patient and biological data to discover and develop precision medicines. Its work is focused primarily on oncology and serves patients with serious diseases through pharmaceutical and healthcare partnerships.
AI/ML
Headquartered in Pittsburgh, Pennsylvania, Axe Compute Inc., established in 2002 and formerly known as Predictive Oncology Inc. until its December 2025 renaming, is an enterprise that leverages profound scientific insights and artificial intelligence (AI) to advance the discovery and development of cancer treatments. The company's operations are divided into two distinct segments. Its Pittsburgh division offers AI-driven services, utilizing an exclusive biobank containing over 150,000 tumor samples, and engineers specialized 3D cell culture models vital for drug advancement. Meanwhile, the Eagan division produces the FDA-approved STREAMWAY System and related products, which facilitate automated medical fluid waste management and direct patient-to-drain fluid disposal. Additionally, Axe Compute maintains a strategic partnership with Every Cure to identify and prioritize existing pharmaceuticals for repurposing.
Search any company we track to see its competitive set.
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
Funding, investors, tech stack, hiring signals, leadership and corporate events — for PredxBio, Inc.and every competitor above — in one live dashboard.
Subscribe to Xcout Intel →